Palmerston North Hospital’s Regional Cancer Treatment Service (RCTS) is home to a new linear accelerator (LINAC), which has replaced an older machine and significantly improved the capacity for treating cancer patients.

There are no new cases of COVID-19 to report in New Zealand today.

The number of active cases in New Zealand remains at 18, all of which are in managed isolation or quarantine facilities. There are no cases of COVID-19 in the community.

The Asthma and Respiratory Foundation NZ (ARFNZ), along with their Scientific Advisory Board members want to see New Zealander’s quit smoking, however not to the detriment of youth.

New Zealand bladder cancer diagnostics provider, Pacific Edge Limited (NZX: PEB), has been notified by Novitas [1] that the LCD: Biomarkers for Oncology (L35396) provides coverage for Cxbladder, CPT codes 0012M (Cxbladder Detect) and 0013M (Cxbladder Monitor), for tests performed on or after July

A charitable grants programme offering up to $50,000 a year to help individuals and groups with education and team projects has just been established by HealthCarePlus, the specialist health insurance plan established by the unions in the education and public services sectors.

Waitematā DHB renal doctor Janak de Zoysa has received just over $1 million from the Health Research Council to participate in an international study to improve health outcomes for dialysis patients.

Canterbury DHB’s Information Services Group (ISG) is now able to safely disinfect devices such as tablets and cell phones when they are returned to ISG from wards and clinical units.

Northland DHB is working towards increasing their capacity to provide staff training in an evidence-based programme designed to deliver coping strategies and support to whānau affected by a loved one’s substance use.

Today there are two new cases of COVID-19 to report in managed isolation and quarantine facilities in New Zealand. There continue to be no new cases in the community.

"We’re pleased with the Advertising Standards Authority’s decision regarding complaints received about our ‘Vote Yes On Our Terms’ cannabis control referendum campaign", said Ross Bell, Drug Foundation Executive Director.